Search
for
Sort by
Research 91–120 of 1000+
- A concise review- Development of an analytical method and validation of dutasteride
- Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Anti-androgenic activities of Ganoderma lucidum
- Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum
- Endocrine control of benign prostatic hyperplasia
- Effect of Citrullus colocynthis Schard on Testosterone-Induced Benign Prostatic Hyperplasia
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2
- Evaluating Carthamus Oxyacantha For 5α-Reductase Inhibition: Therapeutic Perspectives In BPH
- Hormonal manipulation of benign prostatic hyperplasia
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Dutasteride: a guide to its use as monotherapy in benign prostatic hyperplasia
- Pharmacological Effects of the Lipidosterolic Extract from Kigelia africana Fruits in Experimental Benign Prostatic Hyperplasia Induced by Testosterone in Sprague Dawley Rats
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- 5-Alpha reductase deficiency
- Recent advances in treatment for Benign Prostatic Hyperplasia
- Clinical use of 5α-reductase inhibitors
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction
- Current treatment of BPH
- 5α-reductase inhibitors/finasteride
- 5alpha-reductase inhibitors/finasteride.
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Finasteride
- ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW
- Serenoa repens (Saw palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part I
- Clinical applications of antiandrogens